SEC Filing Timeline
8-KOct 08, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
S-3Aug 31, 2026
Shelf registration
10-QAug 05, 2026
Quarterly report
8-KAug 05, 2026
Executive officer change · Items 2.02,5.02,9.01
8-KJun 18, 2026
Shareholder vote results · Items 5.07
424B5May 26, 2026
Prospectus / offering
8-KMay 26, 2026
Material agreement · Items 1.01,8.01,9.01
8-KMay 26, 2026
Other material event · Items 8.01
424B5May 26, 2026
Prospectus / offering
8-KMay 26, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KMay 14, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
10-QMay 05, 2026
Quarterly report
8-KMay 05, 2026
Earnings release · Items 2.02,9.01
DEFA14AApr 28, 2026
Additional proxy
DEF 14AApr 28, 2026
Proxy statement
Recent News (Finnhub)
Sector Update: Healthcare Stocks Softer Late Afternoon
Editas Medicine Gets Clearance For First Human Trial Of Gene-Editing Drug – Wells Fargo Sees Potential For Major Value Upside I…
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
Editas Medicine Receives Approval To Initiate Its Phase 1/2 Strive Clinical Trial Of EDIT-401 In Patients With Heterozygous Fam…
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement